Nuvilex (NASDAQ:PMCB) Shares Cross Below 50 Day Moving Average – What’s Next?

Nuvilex Inc. (NASDAQ:PMCB) shares passed below its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $0.40 and traded as low as $0.2469. Nuvilex shares last traded at $0.3990, with a volume of 1,268,048 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut Nuvilex from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, September 2nd. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Nuvilex Stock Down 0.8%

The business has a 50-day moving average price of $0.40 and a two-hundred day moving average price of $0.62. The company has a market capitalization of $4.28 million, a price-to-earnings ratio of -0.17 and a beta of 0.78.

Nuvilex (NASDAQ:PMCB) last issued its quarterly earnings data on Monday, September 14th. The company reported ($0.54) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.48).

Nuvilex Company Profile

Nuvilex, Inc. was a biotechnology company that later changed its name to PharmaCyte Biotech, Inc. and continued to trade under the ticker symbol PMCB. The company focused on developing cellular therapies intended to treat serious diseases, particularly cancer and diabetes. Its primary technology involved encapsulating genetically engineered human cells in proprietary cellulose-based capsules. These cells were designed to produce therapeutic substances inside the body while limiting exposure to healthy tissue.